MDSpire - MDSpire Home

Region

United States US publications and network International Global sites and content

The premier global destination for healthcare professionals looking for trusted clinical content, breaking news, and a wealth of educational resources.

Conexiant.com
Conexiant Education

Your go-to partner for innovative solutions. Explore the benefits with Conexiant Solutions.

Conexiant DXP

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

MDSpire.com

Association Partner

Our vision is a world free from digestive diseases. That's why it's our mission to empower clinicians and researchers to improve digestive health.

gastro.org
agau.org.gastro
myaga.gastro.org
foundation.gastro.org
agajournals.org
healthecareers.com

Conexiant.com
Conexiant Education

Conexiant DXP

MDSpire.com

gastro.org
myaga.gastro.org
agajournals.org
agau.org.gastro
foundation.gastro.org

Advertisement

What is MDSpire?

MDSpire is an innovative platform aiming to create a smarter, faster, and more connected medical community.

Learn More

Choose specialties Cardiology Dental Dermatology Endocrinology Family Medicine Gastroenterology Hematology Internal Medicine Neurology ObGyn Oncology Ophthalmology Optometry Pediatrics Rheumatology Pulmonary Psychiatry Pathology Surgery Orthopedic Medicine Radiology Otolaryngology Infectious Disease

March 13, 2026

Links Between Depression and Alzheimer’s

Henry Thomas
March 13, 2026
2 min

Depression and Alzheimer's disease share multiple biological mechanisms, as evidenced in a narrative review. Key processes include oxidative stress, mitochondri

...more

Depression and Alzheimer's share biological mechanisms.
Up to 90% of Alzheimer's patients may show depressive symptoms.
Oxidative stress and mitochondrial dysfunction are significant factors.
Neuropsychiatric symptoms complicate disease management.
Some antidepressants may affect Alzheimer's pathology.
Biomarkers could facilitate early detection.
Understanding depression's role in Alzheimer's is vital for treatment strategies.

March 13, 2026

Dry Eye Across Autoimmune Diseases

Julia Cipriano, MS, CMPP
March 13, 2026
3 min

A population-based study conducted in Taiwan reveals that dry eye disease (DED) often precedes autoimmune disease diagnoses by several years, affecting 67,264 p

...more

Dry eye disease (DED) can precede autoimmune diagnosis by approximately 3 years.
Sjögren’s syndrome exhibits the highest prevalence of DED (81%).
Ocular surface complications include keratitis and corneal ulcers.
DED affects females more than males across autoimmune diseases.
Study analyzed data from 67,264 patients using national health records from Taiwan.
Researchers emphasize the importance of early recognition and management of DED.

March 13, 2026

RSV Vaccine Eligibility Expands

Kathryn Wighton
March 13, 2026
3 min

The FDA has expanded the approval for the RSV vaccine Arexvy, now including adults aged 18 to 49 years at increased risk for lower respiratory tract disease cau

...more

FDA expands Arexvy approval to adults 18-49 at increased risk for RSV.
Prior approval was only for those 60+ years and 50-59 with risk factors.
21 million under 50 have RSV risk factors in the US.
Phase 3b trial showed noninferior immune response in younger adults.
Common adverse events include injection site pain and fatigue.
RSV may exacerbate chronic conditions like COPD and asthma.
Vaccine has global approvals and shows safety consistency from trials.

The Medicine Maker

March 13, 2026

Building Quality into Advanced Therapies from Day One

March 13, 2026
7 min

Julie Erwin, Head of Quality Assurance at ProBio US, discusses the evolving regulatory landscape in advanced therapies, emphasizing the need for a nuanced under

...more

Regulatory agencies are adopting nuanced approaches for rare diseases.
Maintaining high GMP standards is essential for safety.
Quality is defined by understanding the product and process.
Communication between CDMO and sponsors is crucial.
Quality-by-Design should start early in development.
A risk-based strategy is necessary for effective quality management.
QA ensures compliance and patient safety throughout the process.
Sponsors should prioritize CDMO capabilities that support early collaboration.

The Ophthalmologist

March 13, 2026

Hydrus®: Designed with Purpose

March 13, 2026
4 min

The Hydrus® Microstent is a cutting-edge device designed for minimally invasive glaucoma surgery, specifically for adults with mild to moderate primary open-ang

...more

- The Hydrus® Microstent is designed for mild to moderate glaucoma patients. - It bypasses the trabecular meshwork, restoring aqueous humour flow. - Created from flexible, biocompatible nitinol material. - Covering over 90 degrees of Schlemm’s canal increases its effectiveness. - Enhances intraocular pressure management without damaging surrounding structures. - Presented by Professor Norbert Pfeiffer at a prominent glaucoma congress.

March 13, 2026

Sleep Duration Signals Metabolic Change

Kathryn Wighton
March 13, 2026
4 min

A study analyzing data from 23,475 U.S. adults reveals an inverted U-shaped correlation between weekday sleep duration and insulin sensitivity, with roughly 7.3

...more

Inverted U-shaped relationship between sleep duration and insulin sensitivity.
Optimal sleep duration for metabolic health is approximately 7.3 hours.
Study included 23,475 adults from NHANES data.
Moderate weekend catch-up sleep improves metabolic markers for those with shorter weekday sleep.
Excessive WCS can weaken insulin sensitivity.
Higher insulin sensitivity associated with shorter sleep in various demographics.
Limitations include cross-sectional design and potential recall bias.

March 13, 2026

Empagliflozin Tested in Real-World Data

Kathryn Wighton
March 13, 2026
3 min

Empagliflozin, a sodium–glucose cotransporter 2 inhibitor, has been linked to reduced all-cause mortality in type 2 diabetes patients compared to dipeptidyl pep

...more

Empagliflozin reduces all-cause mortality in type 2 diabetes.
Compared to DPP-4 inhibitors, empagliflozin shows significant mortality benefits.
Study used data from 62,503 adults, spanning from 2014 to
Majority (83%) of empagliflozin patients did not meet EMPA-REG trial criteria.
Adjusted hazard ratio for decreased mortality with empagliflozin is 0.
Findings confirm real-world efficacy of empagliflozin.
Study emphasizes observational research methods to corroborate randomized trial results.

The Medicine Maker

March 13, 2026

Engineering Safer Editors for Cystic Fibrosis Mutations

March 13, 2026
2 min

Engineers from the University of Pennsylvania and Rice University have developed new DNA base-editing tools aimed at enhancing gene-editing safety for diseases

...more

New DNA base-editing tools developed for cystic fibrosis.
Focus on cytosine base editors (CBEs) to improve precision.
Unintended edits reduced to less than 1%.
Editors successful in correcting mutations in human cells.
Potential for gene therapies and cellular models in research.

March 13, 2026

HS Linked to Higher Self-Harm, Suicide Risk

Olivia Anderson
March 13, 2026
2 min

A recent study in JAMA Dermatology examines the connection between hidradenitis suppurativa (HS), a chronic inflammatory skin disease, and elevated rates of sel

...more

The study included 9,566 HS patients and 47,827 controls.
3.3% of HS patients experienced self-harm versus 1.1% in controls.
HS patients had higher suicide rates (0.2%) compared to controls (0.1%).
Many HS patients who died by suicide had prior self-harm history (41.7%).
Clinician awareness is crucial in managing HS patients' mental health.
Use of nationwide registry data strengthens the research findings.
Limitations include no clinical measures of HS severity.

The Pathologist

March 13, 2026

What Patients Really Want to Know About Precision Medicine

Helen Bristow
March 13, 2026
1 min

In a detailed video discussion, Sharjeel Chaudhry, a pathologist at Dow University Hospital, Karachi, and Michele Mitchell, a patient advocate, examine the comp

...more

Precision medicine adds complexity to diagnostics.
Importance of understanding molecular pathology.
Role of pathologists in patient education.
Discussion between Sharjeel Chaudhry and Michele Mitchell.
Need for patient empowerment in navigating healthcare.

The Pathologist

March 13, 2026

The Genetic Switch in Pancreatic Cancer

March 13, 2026
3 min

Research published in the Journal of Clinical Investigation reveals how the KRAS signaling pathway influences the aggressiveness of pancreatic cancer by suppres

...more

KRAS pathway activity impacts GATA6 gene levels.
GATA6 is associated with pancreatic tumor differentiation.
Tumors with high GATA6 levels are generally less aggressive.
Blocking KRAS can restore GATA6 levels and sensitivity to chemotherapy.
Oxaliplatin is more effective in the presence of higher GATA
This research indicates new potential treatment strategies.
Understanding molecular switches can aid in diagnosis and treatment decisions.

The Analytical Scientist

March 13, 2026

Alzheimer’s in Full Flow

March 13, 2026
3 min

Researchers at USC's Keck School of Medicine have identified new cerebrovascular indicators that may signal Alzheimer's disease risk by examining blood flow and

...more

New cerebrovascular indicators may signal Alzheimer's risk.
Techniques used include ultrasound and spectroscopy.
Higher vascular stability correlates with lower amyloid levels.
Participants with cognitive impairment show poorer cerebrovascular indicators.
Noninvasive methods are cost-effective for monitoring brain health.

The Analytical Scientist

March 13, 2026

Deep-UV Raman Reveals mRNA Encapsulation in Lipid Nanoparticles

March 13, 2026
2 min

Researchers at the University at Albany unveiled a method utilizing deep-ultraviolet Raman spectroscopy to evaluate the encapsulation of messenger RNA (mRNA) wi

...more

mRNA encapsulation is crucial for therapeutic efficacy.
Deep-ultraviolet Raman spectroscopy distinguishes between encapsulated and free mRNA.
Lipid nanoparticles protect fragile mRNA during delivery.
Distinct vibrational markers indicate lipid-mRNA interactions.
Techniques used include principal component analysis and two-dimensional correlation spectroscopy.
Results can improve the formulation processes for mRNA vaccines.
This method offers a nondestructive evaluation approach.

KFF Health News

March 13, 2026

Clinicians Warn of Fatal Measles Brain Disease

Rae Ellen Bichell
March 13, 2026
4 min

Deepanwita Dasgupta, an eight-year-old from Bangalore, faces paralysis and silence due to subacute sclerosing panencephalitis (SSPE), a severe complication of m

...more

Deepanwita Dasgupta has SSPE from measles.
SSPE complication arises years after measles.
1 in 10,000 measles cases leads to SSPE.
Vaccination dramatically reduces SSPE risk.
SSPE is often fatal or leads to severe disability.
CDC notes a rise in measles cases in the U.S.
Experts warn of increased SSPE incidence with low vaccination rates.
Education on SSPE for clinicians is crucial.

The Ophthalmologist

March 13, 2026

Rayner Expands US Cataract Platform with Anikavisc Acquisition

March 13, 2026
2 min

Rayner has secured US distribution rights for Anikavisc, an ophthalmic viscosurgical device from Visco Technologies Inc., enhancing its cataract surgery offerin

...more

Rayner acquired US rights to Anikavisc from Visco Technologies.
Anikavisc OVD supports cataract surgeries.
Rayner launched its Sophi phaco platform.
Anikavisc enhances Rayner's IOL product offerings.
Customers will not see changes to existing arrangements.
The acquisition streamlines purchasing and offers bundled solutions.
Rayner plans to introduce AI-designed IOL technology by 2026.

The Ophthalmologist

March 13, 2026

Lipid-Derived Biomarkers for NAION

March 13, 2026
4 min

Nonarteritic anterior ischemic optic neuropathy (NAION) is a challenging condition in ophthalmology lacking definitive diagnostic biomarkers. A recent study pub

...more

NAION is a complex condition with unclear pathogenesis.
AIP and TyG indices were tested for association with NAION.
Study included 44 NAION patients, excluding those with hyperlipidemia.
Both indices were elevated in NAION compared to controls.
No correlation found between these indices and optic nerve damage severity.
Study emphasizes metabolic factors in NAION risk.
Further prospective studies are needed to confirm findings.

March 13, 2026

Dual-Frequency Radiofrequency for Facial Laxity?

Kathryn Wighton
March 13, 2026
4 min

A prospective multicenter study evaluated the effectiveness of dual-frequency noninvasive monopolar radiofrequency on facial laxity and lifting over 90 days. Co

...more

Dual-frequency monopolar radiofrequency showed significant efficacy in facial lifting.
92% improvement rated by patients at 90 days.
Study involved 39 participants with a mean age of 54.
No long-lasting adverse events were reported.
Mean procedural pain score was 4.
Treatments had adjustable settings for depth.
Limitations included small sample size and no comparator group.
Study fully funded by Cynosure Lutronic without impact on its conduct.

Archives Of Orthopaedic And Trauma Surgery (Springer)

March 13, 2026

Favorable midterm clinical results of medial unicompartmental knee arthroplasty guided by coronal limb alignment using an image-free navigation system

Kengo Shimozaki
Shingo Shimozaki
Eiji Shimozaki
March 13, 2026

Objective: To evaluate the midterm clinical outcomes of medial UKA performed with alignment-guided targets using image-free navigation, focusing on safety, util

...more

Medial unicompartmental knee arthroplasty (UKA) offers excellent outcomes but is prone to malpositioning and alignment issues with conventional techniques.
Image-free navigation is utilized in this study to enhance coronal limb alignment and minimize tibial resection during medial UKA.
The study included 144 knees with a mean follow-up of 63.1 months, focusing on midterm clinical outcomes and implant-related complications.
Postoperative goals include achieving a hip-knee-ankle angle of 2°–5° varus to improve patient satisfaction while avoiding excessive deformity.
Results indicate that alignment-guided medial UKA using image-free navigation can lead to favorable clinical outcomes and low complication rates.

Advertisement

Advertisement

Recommended

Advertisement

About
Privacy Policy

Follow Us